Moderna/Merck begins late-stage study of skin cancer vaccine combination https://ift.tt/LWog6nu

Data from a mid-stage study had shown that the combination cut the risk of recurrence or death of melanoma, the most deadly form of skin cancer, by 44per cent when compared with Keytruda alone.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/v6FMA5D
Share:

No comments:

Post a Comment

Search This Blog

Powered by Blogger.

Labels

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.